Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Medtronic
Teva
US Army
Chinese Patent Office
Citi
Boehringer Ingelheim
Johnson and Johnson
UBS

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064135

« Back to Dashboard

NDA 064135 describes DEXASPORIN, which is a drug marketed by Pharmafair and Bausch And Lomb and is included in three NDAs. It is available from eleven suppliers. Additional details are available on the DEXASPORIN profile page.

The generic ingredient in DEXASPORIN is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 064135
Tradename:DEXASPORIN
Applicant:Bausch And Lomb
Ingredient:dexamethasone; neomycin sulfate; polymyxin b sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 064135
Suppliers and Packaging for NDA: 064135
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXASPORIN dexamethasone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 064135 ANDA Butler Animal Health Supply 11695-1403 E 11695-1403-5
DEXASPORIN dexamethasone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 064135 ANDA MWI/VetOne 13985-028 E 13985-028-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OPHTHALMICStrength0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Approval Date:Sep 13, 1995TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Argus Health
AstraZeneca
Express Scripts
Merck
Teva
Chubb
Daiichi Sankyo
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.